cannabis indica

Índice completo — página 13 de 77

Estudos 1.201 a 1.300 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2022. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 1.201 a 1.300

  1. 2022

    Monoacylglycerol Lipase (MAGL) Inhibition Impedes the Osteosarcoma Progression by Regulating Epithelial Mesenchymal Transition

    FavorávelEstudo LaboratorialCâncerCâncer — ÓsseoMonoacilglicerol Lipase (MAGL)
  2. 2022

    Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

  3. 2022

    Movement Disorders Secondary to Novel Antiseizure Medications in Pediatric Populations: A Systematic Review and Meta-analysis of Risk

  4. 2022

    Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes

    InconclusivoEnsaio ClínicoTEPTTranstorno Bipolar
  5. 2022

    Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer

  6. 2022

    Multiple regulation and targeting effects of borneol in the neurovascular unit in neurodegenerative diseases

    FavorávelMetanáliseInflamaçãoDoenças Neurodegenerativas
  7. 2022

    Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint

  8. 2022

    N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials

  9. 2022

    Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study

  10. 2022

    Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial

  11. 2022

    Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States

    DesfavorávelMetanáliseDependência QuímicaInflamaçãoEfeitos Adversos da Cannabis+9
  12. 2022

    Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Infarto
  13. 2022

    Nerolidol induced apoptosis via PI3K/JNK regulation through cell cycle arrest in MG-63 osteosarcoma cells

    FavorávelEstudo LaboratorialCâncerCâncer — Ósseo
  14. 2022

    Nerolidol: a potential approach in rheumatoid arthritis through reduction of TNF-α, IL-1β, IL-6, NF-kB, COX-2 and antioxidant effect in CFA-induced arthritic model

    FavorávelEstudo em AnimaisArtriteArtrite — Reumatoide
  15. 2022

    Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination

  16. 2022

    Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review

    FavorávelMetanáliseDependência QuímicaDependência — CannabisPsicose+6
  17. 2022

    Neuroplastic alterations in cannabinoid receptors type 1 (CB1) in animal models of epileptic seizures

    FavorávelMetanáliseEpilepsiaEndocanabinoide (não especificado)
  18. 2022

    Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

  19. 2022

    Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-α/NF-κB pathway in Alzheimer's disease rat model

    FavorávelEstudo em AnimaisInflamaçãoAnsiedadeDisfunção CognitivaMedicina Mente-Corpo+5
  20. 2022

    Neuroprotective effects of synthetic borneol and natural borneol based on the neurovascular unit against cerebral ischaemic injury

    FavorávelEstudo LaboratorialAVC
  21. 2022

    Neuropsychological functioning and suicidal behaviours in patients with first-episode psychosis: A systematic review

  22. 2022

    No protective benefits of low dose acute L-glutamine supplementation on small intestinal permeability, epithelial injury and bacterial translocation biomarkers in response to subclinical exertional-heat stress: A randomized cross-over trial

    InconclusivoEnsaio ClínicoProteína Ligadora de Ácidos Graxos (FABP)
  23. 2022

    Non-psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors-, endocannabinoids-, and NF-κB-mediated signaling

  24. 2022

    Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

    FavorávelMetanáliseDorDor — CrônicaDor — AgudaCanabigerol (CBG)
  25. 2022

    Nonpharmacologic management of chronic pain in the United States’ Medicare population: a scoping review protocol

    DesfavorávelMetanáliseDorDor — Crônica
  26. 2022

    Novel and emerging treatment options for acne vulgaris

    FavorávelMetanáliseInflamaçãoAcneMicrobioma
  27. 2022

    Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry

    FavorávelMetanáliseDepressãoAyahuasca
  28. 2022

    NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches

  29. 2022

    Nutritional Interventions to Improve Cachexia Outcomes in Cancer-A Systematic Review

    InconclusivoMetanálise ClínicaCâncerAnorexia (perda de apetite)CaquexiaDietaÔmega-3
  30. 2022

    Observational study of medical marijuana as a treatment for treatment-resistant epilepsies

    InconclusivoMetanáliseEpilepsiaEpilepsia — Lennox-GastautTetraidrocanabinol (THC)
  31. 2022

    Occupational contact urticaria to cannabis sativa

    DesfavorávelMetanáliseDermatite de Contato AlérgicaAlergia à Cannabis
  32. 2022

    Olfactory Stimulation with Volatile Aroma Compounds of Basil ( Ocimum basilicum L.) Essential Oil and Linalool Ameliorates White Fat Accumulation and Dyslipidemia in Chronically Stressed Rats

  33. 2022

    Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome

  34. 2022

    Omega 3 Fatty Acid and Cannabidiol Prolong Lifespan and Ameliorates Brain Ischaemia in Mice Fed Chronic High Fat Diet

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidadeÔmega-3+2
  35. 2022

    Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies

  36. 2022

    Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function

    InconclusivoEstudo em AnimaisDiabetesDoença Renal Crônica
  37. 2022

    Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy

    FavorávelEnsaio ClínicoDorDor — Polineuropatia Induzida por Medicamentos
  38. 2022

    Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment

    DesfavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaPsicose+4
  39. 2022

    Orchestration of the circadian clock and its association with Alzheimer's disease: Role of endocannabinoid signaling

  40. 2022

    Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  41. 2022

    Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells

    FavorávelEstudo LaboratorialCâncerInflamaçãoEstresse OxidativoTetraidrocanabinol (THC)Delta-8-THC+1
  42. 2022

    Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats

  43. 2022

    Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — AgudaCBD Farmacêutico
  44. 2022

    Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)

    DesfavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoEpilepsiaCBD Farmacêutico+1
  45. 2022

    Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice

  46. 2022

    Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial

  47. 2022

    Palmitoylethanolamide-based nutraceutical Calmux® in preventive treatment of migraine

    FavorávelEnsaio ClínicoDorInflamaçãoEnxaquecaPalmitoiletanolamida (PEA)
  48. 2022

    Parkinson’s Disease and Dementia with Lewy Bodies, Patients Under Treatment with Standardized Extracts Enriched in Cannabidiol and Cannabigerol: Descriptive Observations in Preparation for a Phase 2a Clinical Trial

    FavorávelMetanáliseDorAnsiedadePsicoseTetraidrocanabinol (THC)Canabigerol (CBG)+4
  49. 2022

    Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum

  50. 2022

    PEGylated Lecithin-Chitosan Nanoparticle-Encapsulated Alphα-Terpineol for In Vitro Anticancer Effects

    FavorávelEstudo LaboratorialCâncer
  51. 2022

    Penile self-amputation due to cannabis-induced psychosis: a case report

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicose
  52. 2022

    Pentadecanoylcarnitine is a newly discovered endocannabinoid with pleiotropic activities relevant to supporting physical and mental health

  53. 2022

    Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

  54. 2022

    Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity

  55. 2022

    Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy

    DesfavorávelMetanáliseDorEpilepsiaEpilepsia — Síndrome de Dravet+4
  56. 2022

    Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses

    FavorávelEstudo em AnimaisAplicações Veterinárias
  57. 2022

    Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products

    InconclusivoEnsaio Clínico Duplo-CegoCBD Farmacêutico
  58. 2022

    Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDepressãoTetraidrocanabinol (THC)Monoacilglicerol Lipase (MAGL)+3
  59. 2022

    Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses

    FavorávelEstudo em AnimaisAplicações Veterinárias
  60. 2022

    Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study

  61. 2022

    Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice

  62. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  63. 2022

    Pharmacological effects of cannabidiol by transient receptor potential channels

    FavorávelMetanáliseDorCâncerInflamação+6
  64. 2022

    Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature

  65. 2022

    Pharmacological treatment of tremor in multiple sclerosis; a systematic review

    InconclusivoMetanálise ClínicaDoenças NeurodegenerativasEsclerose Múltipla
  66. 2022

    Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway

  67. 2022

    Phycocyanin improved alcohol-induced hepatorenal toxicity and behavior impairment in Wistar rats

    FavorávelEstudo em AnimaisInsuficiência HepáticaDoença Hepática AlcoólicaFicocianina
  68. 2022

    Phycocyanin stimulates ulcerative colitis healing via selective activation of cannabinoid receptor-2, intestinal mucosal healing, Treg accumulation, and p38MAPK/MK2 signaling inhibition

  69. 2022

    Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway

  70. 2022

    Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

  71. 2022

    Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts

  72. 2022

    Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  73. 2022

    Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat

    FavorávelEstudo em AnimaisDisfunção CognitivaDoença de Alzheimer
  74. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  75. 2022

    Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis

  76. 2022

    Plant-Derived Nanoscale-Encapsulated Antioxidants for Oral and Topical Uses: A Brief Review

    FavorávelMetanáliseInflamaçãoEstresse Oxidativo
  77. 2022

    Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves

    FavorávelEstudo em AnimaisAplicações Veterinárias
  78. 2022

    Pneumomediastinum and Pneumorrhachis Associated With Cannabinoid Hyperemesis Syndrome

  79. 2022

    Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum

    DesfavorávelMetanáliseEfeitos Adversos da CannabisNáusea e VômitoGestação+2
  80. 2022

    Popularity of Delta-8 THC on the Internet Across US States, 2021

    FavorávelMetanáliseDelta-8-THC
  81. 2022

    Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review

    InconclusivoMetanáliseCanabigerol (CBG)Canabinol (CBN)+3
  82. 2022

    Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot

  83. 2022

    Potential anti-Parkinsonian's effect of S-(+)-linalool from Cinnamomum osmophloeum ct. linalool leaves are associated with mitochondrial regulation via gas-1, nuo-1, and mev-1 in Caenorhabditis elegans

    FavorávelEstudo LaboratorialDoenças NeurodegenerativasDoença de Parkinson
  84. 2022

    Potential effects of nicotine content in cigarettes on use of other substances

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDependência — Álcool+4
  85. 2022

    Potential Implications of Rimonabant on Age-Related Oxidative Stress and Inflammation

  86. 2022

    Potential protective effect of beta-caryophyllene against cadmium chloride-induced damage to the male reproductive system in mouse

    FavorávelEstudo LaboratorialInflamaçãoEstresse OxidativoInfertilidade Masculina
  87. 2022

    Potential use for chronic pain: Poly(Ethylene Glycol)-Poly(Lactic-Co-Glycolic Acid) nanoparticles enhance the effects of Cannabis-Based terpenes on calcium influx in TRPV1-Expressing cells

    FavorávelEstudo LaboratorialDorDor — Crônica
  88. 2022

    Potential Utility of Cannabidiol in Stress-Related Disorders

  89. 2022

    Potentiation of the Activity of Antibiotics against ATCC and MDR Bacterial Strains with (+)-α-Pinene and (-)-Borneol

    FavorávelEstudo LaboratorialInfecções Bacterianas
  90. 2022

    Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know

  91. 2022

    Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence

  92. 2022

    Predictors of pain reduction among fibromyalgia patients using medical cannabis: a long-term prospective cohort study

    FavorávelEnsaio ClínicoDorAnsiedadeDor — Crônica+3
  93. 2022

    Prefrontal cortical distribution of muscarinic M2 and cannabinoid-1 (CB1) receptors in adult male mice with or without chronic adolescent exposure to Δ9-tetrahydrocannabinol

  94. 2022

    Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis

    FavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+8
  95. 2022

    Premorbid characteristics of patients with DSM-IV psychotic disorders

    DesfavorávelEnsaio ClínicoPsicoseEsquizofreniaTranstorno Bipolar
  96. 2022

    Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents

    DesfavorávelEnsaio ClínicoDisfunção CognitivaGestaçãoTranstornos de Comportamento+2
  97. 2022

    Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes

    InconclusivoMetanáliseDependência QuímicaDisfunção CognitivaSíndrome Metabólica+4
  98. 2022

    Prescription cannabidiol for seizure disorder management: Initial drug-drug interaction management by specialty pharmacists

  99. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+13
  100. 2022

    Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada

    FavorávelMetanáliseDorDor — CrônicaDepressão+6